^
BIOMARKER:

VHL mutation

i
Other names: VHL, von Hippel-Lindau tumor suppressor, RCA1, VHL1, pVHL, HRCA1
Entrez ID:
Related biomarkers:
VHL mutation
Neuroendocrine Tumor
belzutifan
Sensitive: A1 - Approval
VHL mutation
CNS Tumor
belzutifan
Sensitive: A1 - Approval
VHL mutation
RCC
belzutifan
Sensitive: A1 - Approval
VHL mutation
Clear Cell Renal Cell Carcinoma
belzutifan
Sensitive: C1 - Off-label
VHL mutation
GBM
belzutifan
Sensitive: C1 - Off-label
VHL mutation
Clear Cell Renal Cell Carcinoma
PT2385
Sensitive: C2 – Inclusion Criteria
VHL mutation
Neuroendocrine Tumor
PT2385
Sensitive: C3 – Early Trials
VHL mutation
Clear Cell Renal Cell Carcinoma
pazopanib
Resistant: C3 – Early Trials
VHL mutation
RCC
everolimus
Sensitive: C3 – Early Trials
VHL mutation
Cholangiocarcinoma
sunitinib
Sensitive: C4 – Case Studies
VHL mutation
RCC
doxorubicin hydrochloride
Sensitive: D – Preclinical